Does Rallies show Form 4 insider transactions for LFVN?

Yes. Rallies tracks LFVN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is LFVN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LFVN. It does not provide personalized investment advice.

LFVN (Lifevantage Corporation Common Stock (Delaware)) Stock Analysis - Insider Trades

Lifevantage Corporation Common Stock (Delaware) (LFVN) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, LFVN trades at $5.23 with a market cap of $65.48M and a P/E ratio of 6.55. LFVN moved -0.38% today. Year to date, LFVN is -13.79%; over the trailing twelve months it is -60.38%. Its 52-week range spans $3.90 to $27.38. Analyst consensus is neutral with an average price target of $5.00. Rallies surfaces LFVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading LFVN stock inside the company?

Recent LFVN insider activity includes Lewis Darwin bought 1.05K, Dayton Judd bought 10.50K, Dayton Judd bought 18.10K, Dayton Judd bought 4.60K, and Lewis Darwin bought 3.96K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

LFVN Key Metrics

Key financial metrics for LFVN
Metric	Value
Price	$5.23
Market Cap	$65.48M
P/E Ratio	6.55
EPS	$0.80
Dividend Yield	0.05%
52-Week High	$27.38
52-Week Low	$3.90
Volume	3
Avg Volume	0
Revenue (TTM)	$228.53M
Net Income	$9.80M
Gross Margin	80.37%

Recent LFVN Insider Trades

Lewis Darwin bought 1.05K (~$5.52K) on Mar 16, 2026.
Dayton Judd bought 10.50K (~$47.56K) on Mar 2, 2026.
Dayton Judd bought 18.10K (~$83.79K) on Feb 27, 2026.
Dayton Judd bought 4.60K (~$21.07K) on Feb 26, 2026.
Lewis Darwin bought 3.96K (~$20.65K) on Feb 9, 2026.

Latest LFVN News

LifeVantage Q3 Revenue Slumps 25% to $43.7M as Dividend Rises 11% — May 6, 2026
LifeVantage Secures U.S. Patent No. 12,589,067 for Healthy Glow Essentials Stack — Apr 21, 2026
LifeVantage Gains U.S. Patent and Announces CEO Succession, New AXIO Flavors — Apr 20, 2026
LifeVantage Plans May 2026 Portugal Launch with Protandim and Collagen Products — Apr 2, 2026
LifeVantage Q2 Revenue Drops 27.8% to $48.9M; CEO Retirement Planned — Feb 5, 2026

LFVN Analyst Consensus

1 analysts cover LFVN: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.00.

Common questions about LFVN

Who is trading LFVN stock inside the company?: Recent LFVN insider activity includes Lewis Darwin bought 1.05K, Dayton Judd bought 10.50K, Dayton Judd bought 18.10K, Dayton Judd bought 4.60K, and Lewis Darwin bought 3.96K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for LFVN?: Yes. Rallies tracks LFVN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is LFVN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LFVN. It does not provide personalized investment advice.